Document is current

Any future updates will be listed below

ASO Author Reflections: NEO-GAP: A Single-Arm, Phase II Feasibility Trial of Neoadjuvant Gemcitabine, Cisplatin, and Nab-Paclitaxel for Resectable, High-Risk Intrahepatic Cholangiocarcinoma

Crossref DOI link: https://doi.org/10.1245/s10434-023-13811-x

Published Online: 2023-06-29

Published Print: 2023-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark